chapter 14

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Chapter 14

Muscarinic Agonists and Antagonists

2Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Cholinergic Drugs Agents that influence the activity of

cholinergic receptors Most mimic or block the actions of

acetylcholine. Cholinesterase inhibitors

Indirectly prevent the breakdown of acetylcholine

3Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Cholinergic Drugs Toxicology encompasses

Nicotine Insecticides Chemical warfare

4Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

5Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Tips for Understanding the Cholinergic Drugs

Know the receptors that the drug affects. Know the normal responses to activation of

those receptors. Know whether the drug in question increases

or decreases receptor activation.

6Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Master Keys to Cholinergic Drugs

7Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Master Keys to Cholinergic Drugs

8Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Agonists and Antagonists Muscarinic agonists

Bethanechol Other muscarinic agonists Toxicology of muscarinic agonists

Muscarinic antagonists (anticholinergic drugs) Atropine Anticholinergic drugs for overactive bladder (urge

incontinence) Other muscarinic antagonists Toxicology of muscarinic antagonists

9Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Tips for Understanding the Cholinergic Drugs

Bethanechol (prototype drug) Selective agonist at muscarinic cholinergic receptors Refer to Table 14-2. Note the effects muscarinic receptors can produce. Bethanechol activates muscarinic receptors (agonist). Know which receptors a drug interacts with

(Table 14-2) and what those receptors do (Table 14-2). You can predict the types of responses you might expect

from bethanechol.

10Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Agonists and Antagonists Muscarinic agonists

Bethanechol Other muscarinic agonists Toxicology of muscarinic agonists

11Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Agonists and Antagonists Principal structures affected by muscarinic

activation Heart: bradycardia Exocrine glands: increase sweating, salivation,

bronchial secretions, and secretion of gastric acid Smooth muscles

• Contraction in lung (constriction) • GI tract (increased tone/motility) • Bladder (contraction of detrusor) • Vascular (relaxation, vasodilation, hypotension)• Eye (pupillary constriction and ciliary contraction)

12Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Agonists Bethanechol

Mechanism of action Pharmacologic effects

Pharmacokinetics Therapeutic uses

Urinary retention Gastrointestinal uses

13Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Agonists Adverse effects

Cardiovascular system Alimentary system Urinary tract Exacerbation of asthma Dysrhythmias in hyperthyroid patients

Preparations, dosage, and administration

14Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Fig. 14-1. Structures of muscarinic agonists.

15Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Other Muscarinic Agonists Cevimeline

Actions and uses Adverse effects Drug interactions Preparations, dosage, and administration

16Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Other Muscarinic Agonists Pilocarpine

Glaucoma Acetylcholine

Miosis Muscarine

Present in poisonous mushrooms

17Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Overactive Bladder Also known as urgency incontinence,

detrusor instability, and sometimes “can’t-hold-it-anymore” incontinence

Four major symptoms: urinary urgency, urinary frequency, nocturia, and urge incontinence

Urge incontinence often results from involuntary contractions of the bladder detrusor.

18Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Overactive Bladder Affects up to one-third of Americans Can develop at any age, but is most

predominant in elderly patients Two modes of treatment: behavioral therapy

and drug therapy If ineffective—percutaneous tibial nerve

stimulation (PTNS) may be tried.

19Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Antagonists(Anticholinergic Drugs)

Competitively block the actions of acetylcholine at muscarinic receptors

Most muscarinic receptors on structures innervated by parasympathetic nerves

Also known as parasympatholytic drugs, antimuscarinic drugs, muscarinic blockers, and anticholinergic drugs

Anticholinergic drugs: produce selective blockade of muscarinic receptors—not all cholinergic receptors

20Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Antagonists(Anticholinergic Drugs)

Certain drugs (antihistamines, tricyclic antidepressants, phenothiazine antipsychotics) have prominent antimuscarinic actions.

Use with caution—or not at all—with patients receiving other muscarinic antagonists.

21Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Antagonists(Anticholinergic Drugs)

Atropine Best known muscarinic antagonist Found in nature Mechanism of action

• No direct effect of its own• Muscarinic receptor blockade

22Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Antagonists(Anticholinergic Drugs)

Atropine Pharmacologic effects (receptor blockade)

• Heart• Exocrine glands• Smooth muscle• Eye• CNS• Dose dependency of muscarinic blockade• Pharmacokinetics

23Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Antagonists(Anticholinergic Drugs)

Atropine (cont’d) Therapeutic uses

• Preanesthetic medication• Disorders of the eye• Bradycardia• Intestinal hypertonicity and hypermotility• Muscarinic agonist poisoning• Peptic ulcer disease• Asthma• Biliary colic

24Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Antagonists(Anticholinergic Drugs)

Atropine (cont’d) Adverse effects

• Xerostomia (dry mouth)• Blurred vision and photophobia• Elevation of intraocular pressure• Urinary retention• Constipation• Anhidrosis• Tachycardia• Asthma

25Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Antagonists(Anticholinergic Drugs)

Atropine (cont’d) Drug interactions

• Avoid combining atropine with other drugs capable of causing muscarinic blockade

Preparations, dosage, and administration• General systemic therapy• AtroPen for cholinesterase inhibitor poisoning• Ophthalmology

26Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Anticholinergic Drugs for Overactive Bladder

Overactive bladder (OAB): characteristics and overview of treatment

Introduction to anticholinergic therapy of OAB Specific anticholinergic drugs for OAB

Oxybutynin (Ditropan, Oxytrol, Gelnique)• Syrup• Extended-release tablets• Transdermal patch and gel

27Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Anticholinergic Drugs for Overactive Bladder

Specific anticholinergic drugs for OAB (cont’d) Darifenacin Solifenacin Tolterodine

• Immediate-release tablets• Extended-release capsules

Trospium Fesoterodine

28Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Other Muscarinic Antagonists Scopolamine Ipratropium bromide Antisecretory anticholinergics Dicyclomine Pirenzepine and telenzepine Mydriatic-cycloplegics Centrally acting anticholinergics

29Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Toxicology of Muscarinic Agonists Source of muscarinic poisoning

Direct-acting muscarinic agonists Cholinesterase inhibitors

Symptoms Result from excessive activation of muscarinic

receptors Treatment

Muscarinic blocking agent, such as atropine

30Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Toxicology of Muscarinic Antagonists Sources of antimuscarinic poisoning

Natural products Selective antimuscarinic drugs Drugs with pronounced antimuscarinic properties

31Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Toxicology of Muscarinic Antagonists Symptoms

Dry mouth Blurred vision Photophobia Hyperthermia CNS effects Hot, dry, and flushed skin

32Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Toxicology of Muscarinic Antagonists Treatment

Physostigmine Inhibitor of acetylcholinesterase

Warning Differentiate between poisoning and an actual

psychotic episode!